GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Book Value per Share

Kiadis Pharma NV (XAMS:KDS) Book Value per Share : €-0.82 (As of Dec. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Book Value per Share?

Kiadis Pharma NV's book value per share for the quarter that ended in Dec. 2020 was €-0.82.

During the past 12 months, Kiadis Pharma NV's average Book Value Per Share Growth Rate was -170.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Kiadis Pharma NV was 66.10% per year. The lowest was -1.60% per year. And the median was 19.70% per year.

Kiadis Pharma NV's current price is €5.46. Its book value per share for the quarter that ended in Dec. 2020 was €-0.82. Hence, today's PB Ratio of Kiadis Pharma NV is .

During the past 9 years, the highest P/B Ratio of Kiadis Pharma NV was 8.37. The lowest was 0.00. And the median was 0.00.


Kiadis Pharma NV Book Value per Share Historical Data

The historical data trend for Kiadis Pharma NV's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Book Value per Share Chart

Kiadis Pharma NV Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 0.68 0.92 1.81 1.16 -0.82

Kiadis Pharma NV Semi-Annual Data
Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 2.02 1.16 0.69 -0.82

Competitive Comparison of Kiadis Pharma NV's Book Value per Share

For the Biotechnology subindustry, Kiadis Pharma NV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kiadis Pharma NV's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's PB Ratio distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's PB Ratio falls into.



Kiadis Pharma NV Book Value per Share Calculation

Kiadis Pharma NV's Book Value Per Share for the fiscal year that ended in Dec. 2020 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-32.92-0.00)/40.31
=-0.82

Kiadis Pharma NV's Book Value Per Share for the quarter that ended in Dec. 2020 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-32.92-0.00)/40.31
=-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Kiadis Pharma NV  (XAMS:KDS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Kiadis Pharma NV Book Value per Share Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kiadis Pharma NV (XAMS:KDS) Business Description

Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (XAMS:KDS) Headlines

No Headlines